The blood ketone meters market size has grown strongly in recent years. It will grow from $0.44 billion in 2025 to $0.48 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising diabetes prevalence, increased use of ketogenic diets, growing awareness of diabetic ketoacidosis risks, expansion of point-of-care diagnostic devices, improved accessibility of handheld meters.
The blood ketone meters market size is expected to see strong growth in the next few years. It will grow to $0.68 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for connected diagnostic devices, expansion of preventive diabetes management, growing investments in digital health platforms, increasing focus on personalized metabolic monitoring. Major trends in the forecast period include increasing adoption of dual-analyte monitoring devices, rising demand for home-based ketone testing, growing integration of smartphone-connected meters, expansion of continuous ketone monitoring solutions, enhanced focus on early dka detection.
The rising prevalence of diabetes is expected to drive the growth of the blood ketone meters market in the coming years. Diabetes is a chronic condition where the body struggles to regulate blood sugar (glucose) levels effectively. The growing prevalence of diabetes is largely attributed to sedentary lifestyles and poor dietary habits, leading to obesity, insulin resistance, and an increase in type 2 diabetes cases. Blood ketone meters play a crucial role in diabetes management by providing real-time monitoring of ketone levels, helping to detect and prevent diabetic ketoacidosis (DKA). These devices support better treatment decisions by offering accurate, on-the-go insights, enhancing overall patient safety and convenience. For example, in April 2023, the International Diabetes Federation (IDF), a Belgium-based non-profit, reported that approximately 589 million adults worldwide were living with diabetes in 2024, with the number projected to rise to 853 million by 2050. As such, the increasing prevalence of diabetes is contributing to the growth of the blood ketone meters market.
Major companies in the blood ketone meters market are focusing on integrated dual-analyte sensing, such as dual glucose-ketone sensors that measure both blood glucose and ketone (β‑hydroxybutyrate) levels in a single device. These dual sensors use electrochemical biosensing to provide simultaneous, real-time tracking of metabolic (ketone) and glycemic (glucose) states, eliminating the need for separate devices or finger‑stick tests. For example, in June 2025, Tandem Diabetes Care, a U.S.-based diabetes device company, announced plans to integrate Abbott’s upcoming dual glucose-ketone sensor into its automated insulin delivery systems. The sensor is designed to detect rising ketone levels early to help prevent diabetic ketoacidosis, combine glucose and ketone sensing into a single filament to reduce device burden, and work seamlessly with Tandem’s insulin pumps to provide automated safety interventions. This advancement underscores a growing trend in the blood ketone meters market toward comprehensive, automated metabolic monitoring, enhancing both user convenience and clinical safety.
In June 2025, Beta Bionics, a U.S.-based provider of automated insulin delivery systems, partnered with Abbott Laboratories to integrate Abbott’s upcoming dual glucose-ketone sensor into Beta Bionics’ iLet Bionic Pancreas. The partnership aims to enhance real-time decision-making in diabetes management by combining insulin delivery with continuous glucose and ketone monitoring. Abbott Laboratories, based in the U.S., develops next-generation wearable sensors and diagnostic devices for continuous metabolic monitoring, including blood ketone meters.
Major companies operating in the blood ketone meters market are Abbott Laboratories, Roche Diagnostics, Nipro Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Taidoc Technology Corporation, APEX Biotechnology Corporation, EKF Diagnostics Holdings plc, ForaCare Inc., A. Menarini Diagnostics S.r.l., Bioptik Technology Inc., Visgeneer Inc., Keto-Mojo Inc., GlucoRx Ltd., e-LinkCare Meditech Co. Ltd., Ketoscan, Ringbio, Nova Biomedical Corporation, Ascensia Diabetes Care, ARKRAY Inc., i-SENS Inc.
North America was the largest region in the blood ketone meters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood ketone meters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood ketone meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood ketone meters market by increasing costs of imported sensors, microelectronics, test strip materials, and semiconductor components used in portable monitoring devices. Hospitals and homecare users in North America and Europe are most affected due to dependence on imported diagnostic components, while Asia-Pacific faces cost pressures on manufacturing and export activities. These tariffs are raising device prices and consumable costs. However, they are also encouraging domestic electronics manufacturing, localized assembly of monitoring devices, and innovation in cost-efficient diagnostic technologies.
The blood ketone meters market research report is one of a series of new reports that provides blood ketone meters market statistics, including blood ketone meters industry global market size, regional shares, competitors with a blood ketone meters market share, detailed blood ketone meters market segments, market trends and opportunities, and any further data you may need to thrive in the blood ketone meters industry. This blood ketone meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood ketone meters are portable diagnostic tools designed to measure the concentration of ketones - specifically beta-hydroxybutyrate - in the blood. Operating similarly to blood glucose meters, these devices require a small blood sample, usually taken from the fingertip. Their primary function is to monitor ketosis, especially in individuals with diabetes, those following ketogenic diets, or patients at risk of diabetic ketoacidosis (DKA).
The main product categories within blood ketone meters include blood ketone monitoring, combined blood glucose and ketone monitoring, surgical devices, and consumables. Blood ketone monitoring involves assessing beta-hydroxybutyrate levels in the bloodstream using specialized equipment. Testing can be conducted on the fingertip or alternate sites. These devices are used in both human and veterinary applications. Distribution occurs through traditional retail stores and e-commerce platforms. Key end users include hospitals, diagnostic centers, homecare environments, and various other healthcare facilities.
The blood ketone meters market consists of sales of stand-alone blood ketone meters, dual-function meters (glucose + ketone), bluetooth-enabled ketone meters, ketone test strips, lancets, and meter kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood ketone meters market size is expected to see strong growth in the next few years. It will grow to $0.68 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for connected diagnostic devices, expansion of preventive diabetes management, growing investments in digital health platforms, increasing focus on personalized metabolic monitoring. Major trends in the forecast period include increasing adoption of dual-analyte monitoring devices, rising demand for home-based ketone testing, growing integration of smartphone-connected meters, expansion of continuous ketone monitoring solutions, enhanced focus on early dka detection.
The rising prevalence of diabetes is expected to drive the growth of the blood ketone meters market in the coming years. Diabetes is a chronic condition where the body struggles to regulate blood sugar (glucose) levels effectively. The growing prevalence of diabetes is largely attributed to sedentary lifestyles and poor dietary habits, leading to obesity, insulin resistance, and an increase in type 2 diabetes cases. Blood ketone meters play a crucial role in diabetes management by providing real-time monitoring of ketone levels, helping to detect and prevent diabetic ketoacidosis (DKA). These devices support better treatment decisions by offering accurate, on-the-go insights, enhancing overall patient safety and convenience. For example, in April 2023, the International Diabetes Federation (IDF), a Belgium-based non-profit, reported that approximately 589 million adults worldwide were living with diabetes in 2024, with the number projected to rise to 853 million by 2050. As such, the increasing prevalence of diabetes is contributing to the growth of the blood ketone meters market.
Major companies in the blood ketone meters market are focusing on integrated dual-analyte sensing, such as dual glucose-ketone sensors that measure both blood glucose and ketone (β‑hydroxybutyrate) levels in a single device. These dual sensors use electrochemical biosensing to provide simultaneous, real-time tracking of metabolic (ketone) and glycemic (glucose) states, eliminating the need for separate devices or finger‑stick tests. For example, in June 2025, Tandem Diabetes Care, a U.S.-based diabetes device company, announced plans to integrate Abbott’s upcoming dual glucose-ketone sensor into its automated insulin delivery systems. The sensor is designed to detect rising ketone levels early to help prevent diabetic ketoacidosis, combine glucose and ketone sensing into a single filament to reduce device burden, and work seamlessly with Tandem’s insulin pumps to provide automated safety interventions. This advancement underscores a growing trend in the blood ketone meters market toward comprehensive, automated metabolic monitoring, enhancing both user convenience and clinical safety.
In June 2025, Beta Bionics, a U.S.-based provider of automated insulin delivery systems, partnered with Abbott Laboratories to integrate Abbott’s upcoming dual glucose-ketone sensor into Beta Bionics’ iLet Bionic Pancreas. The partnership aims to enhance real-time decision-making in diabetes management by combining insulin delivery with continuous glucose and ketone monitoring. Abbott Laboratories, based in the U.S., develops next-generation wearable sensors and diagnostic devices for continuous metabolic monitoring, including blood ketone meters.
Major companies operating in the blood ketone meters market are Abbott Laboratories, Roche Diagnostics, Nipro Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Taidoc Technology Corporation, APEX Biotechnology Corporation, EKF Diagnostics Holdings plc, ForaCare Inc., A. Menarini Diagnostics S.r.l., Bioptik Technology Inc., Visgeneer Inc., Keto-Mojo Inc., GlucoRx Ltd., e-LinkCare Meditech Co. Ltd., Ketoscan, Ringbio, Nova Biomedical Corporation, Ascensia Diabetes Care, ARKRAY Inc., i-SENS Inc.
North America was the largest region in the blood ketone meters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood ketone meters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood ketone meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood ketone meters market by increasing costs of imported sensors, microelectronics, test strip materials, and semiconductor components used in portable monitoring devices. Hospitals and homecare users in North America and Europe are most affected due to dependence on imported diagnostic components, while Asia-Pacific faces cost pressures on manufacturing and export activities. These tariffs are raising device prices and consumable costs. However, they are also encouraging domestic electronics manufacturing, localized assembly of monitoring devices, and innovation in cost-efficient diagnostic technologies.
The blood ketone meters market research report is one of a series of new reports that provides blood ketone meters market statistics, including blood ketone meters industry global market size, regional shares, competitors with a blood ketone meters market share, detailed blood ketone meters market segments, market trends and opportunities, and any further data you may need to thrive in the blood ketone meters industry. This blood ketone meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood ketone meters are portable diagnostic tools designed to measure the concentration of ketones - specifically beta-hydroxybutyrate - in the blood. Operating similarly to blood glucose meters, these devices require a small blood sample, usually taken from the fingertip. Their primary function is to monitor ketosis, especially in individuals with diabetes, those following ketogenic diets, or patients at risk of diabetic ketoacidosis (DKA).
The main product categories within blood ketone meters include blood ketone monitoring, combined blood glucose and ketone monitoring, surgical devices, and consumables. Blood ketone monitoring involves assessing beta-hydroxybutyrate levels in the bloodstream using specialized equipment. Testing can be conducted on the fingertip or alternate sites. These devices are used in both human and veterinary applications. Distribution occurs through traditional retail stores and e-commerce platforms. Key end users include hospitals, diagnostic centers, homecare environments, and various other healthcare facilities.
The blood ketone meters market consists of sales of stand-alone blood ketone meters, dual-function meters (glucose + ketone), bluetooth-enabled ketone meters, ketone test strips, lancets, and meter kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Ketone Meters Market Characteristics
3. Blood Ketone Meters Market Supply Chain Analysis
4. Global Blood Ketone Meters Market Trends and Strategies
5. Blood Ketone Meters Market Analysis of End Use Industries
7. Global Blood Ketone Meters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Ketone Meters Total Addressable Market (TAM) Analysis for the Market
9. Blood Ketone Meters Market Segmentation
10. Blood Ketone Meters Market Regional and Country Analysis
11. Asia-Pacific Blood Ketone Meters Market
12. China Blood Ketone Meters Market
13. India Blood Ketone Meters Market
14. Japan Blood Ketone Meters Market
15. Australia Blood Ketone Meters Market
16. Indonesia Blood Ketone Meters Market
17. South Korea Blood Ketone Meters Market
18. Taiwan Blood Ketone Meters Market
19. South East Asia Blood Ketone Meters Market
20. Western Europe Blood Ketone Meters Market
21. UK Blood Ketone Meters Market
22. Germany Blood Ketone Meters Market
23. France Blood Ketone Meters Market
24. Italy Blood Ketone Meters Market
25. Spain Blood Ketone Meters Market
26. Eastern Europe Blood Ketone Meters Market
27. Russia Blood Ketone Meters Market
28. North America Blood Ketone Meters Market
29. USA Blood Ketone Meters Market
30. Canada Blood Ketone Meters Market
31. South America Blood Ketone Meters Market
32. Brazil Blood Ketone Meters Market
33. Middle East Blood Ketone Meters Market
34. Africa Blood Ketone Meters Market
36. Blood Ketone Meters Market Competitive Landscape and Company Profiles
37. Blood Ketone Meters Market Other Major and Innovative Companies
40. Blood Ketone Meters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Ketone Meters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood ketone meters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood ketone meters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood ketone meters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Blood Ketone Monitoring; Blood Glucose And Ketone Monitoring; Continuous Ketone Monitoring Devices; Consumables2) By Testing Site: Fingertip Testing; Alternate Site Testing
3) By Application: Human; Veterinary
4) By Distribution Channel: Brick And Mortar; E-commerce
5) By End-Use: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Uses
Subsegments:
1) By Blood Ketone Monitoring: Handheld Ketone Meters; Wearable Ketone Monitors; Integrated Smartphone-Compatible Meters2) By Blood Glucose And Ketone Monitoring: Dual-Analyte Meters; Continuous Glucose-Ketone Monitors; Bluetooth-Enabled Hybrid Devices
3) By Continuous Ketone Monitoring Devices: Continuous Ketone Sensors; Non-Invasive Or Minimally Invasive Ketone Sensors; Clinical-Grade Ketone Meters
4) By Consumables: Ketone Test Strips; Control Solutions; Lancets And Lancing Devices; Sensor Adhesives And Patches
Companies Mentioned: Abbott Laboratories; Roche Diagnostics; Nipro Corporation; Lepu Medical Technology (Beijing) Co. Ltd.; Taidoc Technology Corporation; APEX Biotechnology Corporation; EKF Diagnostics Holdings plc; ForaCare Inc.; A. Menarini Diagnostics S.r.l.; Bioptik Technology Inc.; Visgeneer Inc.; Keto-Mojo Inc.; GlucoRx Ltd.; e-LinkCare Meditech Co. Ltd.; Ketoscan; Ringbio; Nova Biomedical Corporation; Ascensia Diabetes Care; ARKRAY Inc.; i-SENS Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Ketone Meters market report include:- Abbott Laboratories
- Roche Diagnostics
- Nipro Corporation
- Lepu Medical Technology (Beijing) Co. Ltd.
- Taidoc Technology Corporation
- APEX Biotechnology Corporation
- EKF Diagnostics Holdings plc
- ForaCare Inc.
- A. Menarini Diagnostics S.r.l.
- Bioptik Technology Inc.
- Visgeneer Inc.
- Keto-Mojo Inc.
- GlucoRx Ltd.
- e-LinkCare Meditech Co. Ltd.
- Ketoscan
- Ringbio
- Nova Biomedical Corporation
- Ascensia Diabetes Care
- ARKRAY Inc.
- i-SENS Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.48 Billion |
| Forecasted Market Value ( USD | $ 0.68 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
